SUMMARY The use of fluorescein-conjugated monoclonal antibody (Syva, UK) provided a rapid reliable diagnostic test for Chlamydia trachomatis in conjunctival samples from 100 adults with acute follicular conjunctivitis and seven babies with suspected chlamydial ophthalmia neonatorum. Elementary bodies (EBs) were seen in smears from 11 of the adults, and culture confirmed C. trachomatis infection in nine of them. Both tests were positive with specimens from four of the neonates. No specimens from either group of patients produced a negative result in the smear test but a positive result by culture. However, the two adult patients with chlamydial ophthalmia who had negative cultures but were EB-positive had both had prior topical tetracycline therapy.
Acute follicular conjunctivitis is a common problem in general practice and eye casualty departments. Many cases will be due to adenovirus infection and may resolve with symptomatic therapy. An important minority of cases, however, will be due to infection with oculogenital strains of Chlamydia trachomatis, when there may be concurrent (often asymptomatic) genital infection for which there is specific therapy.
Definitive diagnosis of conjunctival infection with C. trachomatis may be made by detecting inclusions in conjunctival cell scrapings or by isolating the organism in cell culture. 1-3 The latter method is more sensitive, but as chlamydiae are labile care must be taken with storage and transport of specimens to the laboratory. In addition isolation of chlamydiae in cell culture requires experience and constant control of sensitivity. Specimens are inoculated into McCoy cell cultures, and after 48 or 72 hours chlamydial inclusions are stained with Giemsa (or iodine) reagent.
Direct demonstration of inclusions in conjunctival scrapings stained with Giemsa provides a result within an hour of the specimen arriving at the laboratory, but it is a less sensitive method than culture. In proved chlamydial eye infections Giemsa staining of conjunctival smears detected up to only 60% of cases, and fluorescent polyclonal antibody staining detected 80%.34 However, very few inclusions are found even by the fluorescent antibody technique, so that often a prolonged search for the agent is necessary.
The ability to detect reliably extracellular elementary bodies (EBs) directly in conjunctival smears would obviate both the need for culture and its associated problems, and the laborious search for inclusions in conjunctival scrapings. Recently a fluorescein-labelled monoclonal antibody specific to C. trachomatis has become available and allows the more numerous EBs to be detected rapidly. This technique has been shown to be sensitive and specific, when compared with isolation, in detecting chlamydiae in specimens from the genital tract (urethra, cervix).56
The monoclonal antibody recognises specifically the major outer membrane protein (MOMP) of all 15 serovars (immunotypes) of C. trachomatis-that is A, B, and C, causing trachoma, the oculogenital strains (D-K), and L1-L3 causing lymphogranuloma venereum-but it does not cross-react with C. psittaci.'
Patients and methods

PATI ENTS
One hundred adult patients with acute follicular conjunctivitis and seven babies with ophthalmia neonatorum were studied. by immersing the slide in distilled water, followed by a 5 min wash with stirring. After being dried the smear was mounted under a coverslip with Microtrak chlamydia direct specimen mounting fluid and examined with a Nikon L-ke microscope fitted with an epifluorescence attachment.
All the smears were coded and then read by one observer (BJT), who also examined coded Giemsastained McCoy cell monolayers at a later date. All 
All other patients had negative IF/Giemsa/CC at initial visit and were not further tested.
IF=Immunofluorescence. CC=Culture confirmation. NT=Not tested. ±=1-10. +=11-100. ++ =101-1000. +++=1001-10000. ++++=>10000. The above ranges (± to + + + +) apply to elementary bodies seen in the direct test or inclusions seen in cell monolayers when the culture technique is used. 
Effect of therapy on direct test and culture
Topical treatment. Topical tetracyclines appear to have a greater effect on culture than on the direct test. Thus a smear from the right eye of patient 49 contained 10-100 EBs while the culture was negative. This patient had been using tetracycline and Albucid (sulphacetamide) eye drops for 10 days prior to her presentation. Consequently the EBs seen may not have been viable. Unfortunately the patient defaulted, so that the follow-up genital tests were not possible. The other culture-negative patient (no. 44) had fewer than 10 EBs in a conjunctival smear from her left eye and had also received prior topical tetracycline therapy (tetracycline ointment for two weeks). Patient 67 had both eyes positive by both tests from samples taken at presentation. One day later, however, after topical tetracycline therapy chlamydiae were not isolated by culturing specimens from the right eye, although >100 EBs were shown by direct immunofluorescence (Table 2) . Systemic treatment. Attempts to visualise EBs directly and to culture chlamydiae in cell culture from genital and eye sites were unsuccessful after one week or more of systemic tetracycline therapy. In one patient (no. 46), however, 10-100 EBs were seen after six days in a specimen from what had been a severely affected left eye, but the result of culture was negative (Table 3) . Presumably these were dead EBs.
NEONATES
EBs were detected in the conjunctival smears of 4 (57%) of seven babies with suspected chlamydial conjunctivitis. C. trachomatis was cultured in every case and, conversely, the micro-organism could not be cultured in the three smear-negative babies. One of these positive smears had fewer than 10 EBs, whereas the other three had more than 100.
MICROIMMUNOFLUORESCENCE SEROLOGY
This was performed only on patients who had genital tests. All except patient number 44 were positive with IgG titres (against pooled D-K, lymphogranuloma venereum antigens) ranging from 1: 16-1:128.
Discussion
The results of the study show that conjunctivitis caused by oculogenital strains of C. trachomatis can be diagnosed rapidly and easily by staining conjunctival smears with a fluorescent monoclonal antibody.
The conjunctival swabs were taken by a number of different medical and nursing staff in a busy eye casualty department. Nevertheless, samples from clinically affected eyes usually contained sufficient epithelial cells to indicate that they were adequate for testing. On the few occasions when inadequate smears were provided they were readily identified, and additional specimens were requested if this was clinically indicated. Eye specimens produced few non-specifically staining artefacts compared with genital specimens and so were easy to interpret. We considered as artefacts any fluorescing particles which did not have the characteristic EB morphology, colour, and brightness.5' ' Subsequent to this study we have looked at a number of conjunctival smears taken soon after patients had applied ointment based preparations. These smears were covered with numerous fluorescent globules, which could not be confused with EBs, but made the search for small numbers of them more difficult.
The fluorescent monoclonal antibody test for EBs was at least as sensitive as routine cell culture for detecting chlamydial eye disease. It was also highly specific, though patient 44 had negative genital tests and microimmunofluorescence serology, so that the result in her case may have been a false positive."I 12 All the eye samples found to be negative by the monoclonal antibody test were confirmed as negative by culture. The high specificity and sensitivity of the test support our claim that the technique is reliable. This does not surprise us considering previous reports of success with samples from the genital tract. 56 Although the prevalence of chlamydial ophthalmia in the United Kingdom is unknown, in a large study over five years (1976-80) 18% of new patients attending the Keratoconjunctivitis Clinic at Moorfields Eye Hospital were diagnosed as having adult chlamydial ophthalmia.' However, in a recent study from the same hospital of 142 consecutive patients with acute conjunctivitis only 7 (5%) of the patients had chlamydial infection confirmed by culture, though serological evidence suggestive of infection was found in another 5 (4%) of the patients.'3 Ours was not a prevalence study, but the positivity rate, despite some selection, was only 11%. It is probable that this rate was reduced by an adenovirus epidemic at the time of the study. As noted by others, patients with chlamydial ophthalmia could not be readily identified by history and examination. Positive patients were not necessarily particularly promiscuous, and many had asymptomatic genital infections.
The use of the monoclonal antibody technique to diagnose chlamydial eye disease has obvious advantages. First, the problems of storage and transport of specimens associated with an isolation service in a distant laboratory are eliminated. Second, selected patients, for example neonates with conjunctivitis, can be offered a very rapid service, with results available within 30 minutes of the specimen reaching the laboratory. Third, the test is relatively painless compared with conjunctival scrapings (the other method with which rapid results can be obtained). Finally, the-combination of a quick and reliable technique will allow the early identification of those patients who require systemic therapy for both eye disease and genital tract infection. 
